The government has approved the Health Ministry's proposal to promote and expand research and clinical trial activities in Israel, a phase that serves as a gateway for innovative medical technologies into the system and the provision of groundbreaking treatments. The decision includes simplification of bureaucratic procedures and decentralization of authority, alongside the establishment of an efficient mechanism for mutual recognition of approvals between Helsinki committees at different hospitals to prevent duplication, and fast digital application submission.

